newsfilter
← Latest News
ACCESS Newswire·

NovAccess Global Announces Uplisting to OTCQB

CLEVELAND, OH / ACCESSWIRE / August 10, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that the trading of its common shares has been upgraded to the OTC Markets